Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase EARLY_PHASE1 2Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Tobacco Use Cessation 1Smoking Cessation 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Focus Groups × Clear all
NCT04474184 2023-11-18

Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates

Mayo Clinic

Phase 1 Completed
33 enrolled
Gynecologic

Endometrial Neoplasms

NCT00513097 2017-11-06

Curbing Tobacco Use in Suburban and Rural Schools

M.D. Anderson Cancer Center

Phase 1 Completed
1,289 enrolled

Smoking Cessation, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡